Legend Biotech (LEGN) Cash from Investing Activities (QoQ) (2019 - 2026)
Legend Biotech (LEGN) Cash from Investing Activities (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Legend Biotech | 7.11 Bn | 6.46 Bn | 129.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.31% |
| Dec 31, 2025 | 3,292.34% |
| Sep 30, 2025 | 87.91% |
| Jun 30, 2025 | -164.49% |
| Mar 31, 2025 | 391.92% |
| Dec 31, 2024 | -126.71% |
| Sep 30, 2024 | 147.31% |
| Jun 30, 2024 | -75.60% |
| Mar 31, 2024 | -197.21% |
| Dec 31, 2023 | 294.91% |
| Sep 30, 2023 | -71.82% |
| Jun 30, 2023 | -859.00% |
| Mar 31, 2023 | -35.70% |
| Dec 31, 2022 | -80.51% |
| Sep 30, 2022 | 4,847.43% |
| Jun 30, 2022 | 101.11% |
| Mar 31, 2022 | -19.24% |
| Dec 31, 2021 | -84.52% |
| Sep 30, 2021 | 37.35% |
| Jun 30, 2021 | -883.52% |